Stifel Financial’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$186M Buy
466,595
+34,907
+8% +$15.3M 0.15% 153
2026
Q1
$199M Sell
431,688
-80,598
-16% -$40.8M 0.18% 135
2025
Q4
$290M Buy
512,286
+42,281
+9% +$22.5M 0.26% 84
2025
Q3
$210M Buy
470,005
+16,165
+4% +$7.76M 0.19% 127
2025
Q2
$247M Buy
453,840
+33,332
+8% +$17.4M 0.24% 92
2025
Q1
$208M Buy
420,508
+24,479
+6% +$13.5M 0.22% 98
2024
Q4
$207M Sell
396,029
-935
-0.2% -$487K 0.22% 102
2024
Q3
$195M Buy
396,964
+16,458
+4% +$7.66M 0.2% 113
2024
Q2
$169M Buy
380,506
+6,981
+2% +$2.78M 0.19% 119
2024
Q1
$149M Sell
373,525
-4,391
-1% -$1.66M 0.17% 137
2023
Q4
$127M Buy
377,916
+23,405
+7% +$6.98M 0.16% 145
2023
Q3
$104M Buy
354,511
+15,350
+5% +$4.79M 0.15% 156
2023
Q2
$116M Sell
339,161
-32,651
-9% -$9.88M 0.16% 143
2023
Q1
$95M Sell
371,812
-86,620
-19% -$21.3M 0.14% 163
2022
Q4
$122M Sell
458,432
-4,268
-0.9% -$1.04M 0.18% 132
2022
Q3
$86.7M Sell
462,700
-17,170
-4% -$3.69M 0.14% 162
2022
Q2
$96.3M Buy
479,870
+15,796
+3% +$3.71M 0.15% 153
2022
Q1
$140M Buy
464,074
+29,038
+7% +$8.48M 0.19% 124
2021
Q4
$156M Buy
435,036
+59,085
+16% +$20.3M 0.21% 112
2021
Q3
$125M Buy
375,951
+12,741
+4% +$4.28M 0.18% 125
2021
Q2
$111M Buy
363,210
+13,245
+4% +$3.72M 0.17% 137
2021
Q1
$86.2M Buy
349,965
+32,799
+10% +$8.25M 0.14% 156
2020
Q4
$86.5M Buy
317,166
+11,898
+4% +$2.95M 0.15% 147
2020
Q3
$72.2M Buy
305,268
+4,851
+2% +$1.09M 0.15% 146
2020
Q2
$57.1M Buy
300,417
+1,089
+0.4% +$195K 0.13% 165
2020
Q1
$48M Buy
299,328
+101,442
+51% +$18.6M 0.13% 173
2019
Q4
$39.1M Buy
197,886
+66,585
+51% +$12.5M 0.08% 240
2019
Q3
$23.7M Sell
131,301
-3,510
-3% -$607K 0.06% 285
2019
Q2
$23.6M Buy
134,811
+7,059
+6% +$1.21M 0.06% 284
2019
Q1
$24.3M Sell
127,752
-6,936
-5% -$1.23M 0.07% 271
2018
Q4
$21.5M Buy
134,688
+3,063
+2% +$519K 0.07% 269
2018
Q3
$25.1M Buy
131,625
+31,653
+32% +$5.62M 0.07% 266
2018
Q2
$15.9M Buy
99,972
+13,344
+15% +$2.03M 0.05% 380
2018
Q1
$11.9M Buy
86,628
+900
+1% +$126K 0.04% 468
2017
Q4
$10.4M Sell
85,728
-25,044
-23% -$3.13M 0.03% 514
2017
Q3
$10.5M Buy
110,772
+35,568
+47% +$3.88M 0.04% 488
2017
Q2
$7.84M Buy
75,204
+7,569
+11% +$727K 0.03% 565
2017
Q1
$5.76M Buy
67,635
+4,482
+7% +$354K 0.02% 648
2016
Q4
$4.46M Sell
63,153
-162,270
-72% -$11.9M 0.02% 700
2016
Q3
$18.1M Sell
225,423
-189
-0.1% -$14.5K 0.08% 263
2016
Q2
$16.6M Sell
225,612
-93,240
-29% -$6.56M 0.08% 265
2016
Q1
$21.3M Buy
318,852
+22,734
+8% +$1.41M 0.11% 199
2015
Q4
$18M Sell
296,118
-5,769
-2% -$324K 0.09% 237
2015
Q3
$15.4M Buy
301,887
+27,234
+10% +$1.54M 0.09% 253
2015
Q2
$14.8M Buy
274,653
+8,676
+3% +$485K 0.08% 283
2015
Q1
$14.9M Buy
265,977
+2,871
+1% +$163K 0.08% 288
2014
Q4
$15.5M Buy
263,106
+12,402
+5% +$691K 0.09% 289
2014
Q3
$12.9M Buy
250,704
+207
+0.1% +$10.3K 0.11% 223
2014
Q2
$11.5M Sell
250,497
-549
-0.2% -$24.2K 0.1% 261
2014
Q1
$12.2M Buy
+251,046
New +$11.8M 0.12% 232

Other funds holding ISRG

Stifel Financial's ISRG Position: Q2 2026 in Review

Stifel Financial increased its Intuitive Surgical (ISRG) stake by 8.1% in Q2 2026, buying an estimated $15.3M and bringing the position to 466,595 shares worth $186M. The position accounts for 0.15% of the portfolio, ranked #153.

Stifel Financial first reported a position in ISRG in Q1 2014 and has held it in 50 quarters since. The position peaked at $290M in Q4 2025. 2,231 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Stifel Financial held 466,595 shares of Intuitive Surgical worth $186M as of Q2 2026.
  • Stifel Financial bought 34,907 Intuitive Surgical shares in Q2 2026, an estimated $15.3M.
  • Intuitive Surgical made up 0.15% of Stifel Financial's portfolio in Q2 2026, its #153 holding.
  • Stifel Financial first reported a position in Intuitive Surgical in Q1 2014 and has held it in 50 quarters since.
  • Stifel Financial's Intuitive Surgical position peaked at $290M in Q4 2025.
  • 2,231 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.